Skip to main content

Table 2 Comparison of contrast-enhanced ultrasound features between patients with and without upgrade to malignancy after surgery

From: Contrast-enhanced ultrasound to predict malignant upgrading of atypical ductal hyperplasia

Variable

Surgical pathology results

Univariable Analysis

Malignant

Nonmalignant

Odds Ratio (95%CI)

P value

Wash-in time

Meantime/Later

1 (1.9)

14 (24.6)

1 (reference)

 

Earlier

52 (98.1)

43 (75.4)

16.93 (2.14, 133.98)

0.007

Enhancement degree

Hypo-enhancement

1 (1.9)

10(17.5)

1 (reference)

 

Iso-enhancement

1 (1.9)

4 (7.0)

2.50 (0.12, 50.44)

0.550

Hyper-enhancement

51 (96.2)

43 (75.4)

11.86 (1.46, 96.40)

0.021

Enhancement direction

Centrifugal/Diffuse

2 (3.8)

9 (15.8)

1 (reference)

 

Centripetal

51(96.2)

48(84.2)

4.78 (0.98,23.26)

0.053

Perfusion defects

Absent

37 (69.8)

53 (93.0)

1 (reference)

 

Present

16 (30.2)

4 (7.0)

5.73 (1.77,18.52)

0.004

Internal homogeneity

Homogeneous

7 (13.2)

26 (45.6)

1 (reference)

 

Heterogeneous

46 (86.8)

31 (54.4)

5.51 (2.13,14.26)

 < 0.001

Enhancement margin

Well-defined

10 (18.9)

37 (64.9)

1 (reference)

 

Ill-defined

43 (81.1)

20 (35.1)

7.95 (3.31,19.12)

 < 0.001

Enhancement shape

Round/Oval

9 (17.0)

36 (63.2)

1 (reference)

 

Irregular

44 (83.0)

21 (36.8)

8.38 (3.42,20.54)

 < 0.001

Size on CEUS

Not enlarged

15 (28.3)

47 (82.5)

1 (reference)

 

Enlarged

38 (71.7)

10 (17.5)

11.91 (4.81,29.50)

 < 0.001

Radial or penetrating vessels

Absent

33 (62.3)

56 (98.2)

1 (reference)

 

Present

20 (37.7)

1 (1.8)

33.94 (4.35,264.67)

0.001

  1. Variables are expressed as numbers of lesions with percentages in parentheses